NBTY, Inc. (NYSE: NTY) on Thursday announced Thursday that it has agreed to be acquired by Carlyle Group in a transaction valued at $3.8 billion. Under the terms of the merger agreement, Carlyle will acquire all of the outstanding common shares of NBTY for $55.00 per share in cash; representing a premium of approximately 57% over NBTY's average closing share price during the 30 trading days ended July 14, 2010. NBTY shares jumped more than 44% in pre-market trading.
WuXi PharmaTech (Cayman) Inc. (NYSE: WX) on Thursday announced its preliminary financial highlights for second-quarter 2010. The company said that it expects second quarter net income in the range of $13.3 million to $14.0 million and earnings per ADS in the range of 18 cents to 19 cents. It anticipates non-GAAP net income in the range of $19.4 million to $20.1 million and non-GAAP earnings per ADS in the range of 26 cents- 27 cents. The company said that it now expects to report second-quarter revenue of $81.0 million, up from its prior forecast in the range of $76 million to $78 million.
OPNET Technologies Inc. (NASDAQ: OPNT) said late Wednesday that it now expects to report fiscal quarter revenue in the range of $30.9 to $31.1 million, down from its prior guidance in the range of $32.0 to $34.5 million. Based on these preliminary estimated financial results, diluted earnings per share for the first quarter of fiscal 2011 are expected to be between $0.05 and $0.06, within the previously guided range of $0.03 to $0.08. Analysts currently expect the company to earn $0.11 per share on revenue of $33.65 million for the first quarter.
A Food and Drug Administration advisory panel recommended Wednesday that GlaxoSmithKline's (NYSE: GSK) controversial diabetes drug Avandia be allowed to remain on the market — but with tighter supervision and increased warnings because it increases the risks of heart attacks.
Disclosure: Author doesn't own any of the stocks discussed here.
